BACKGROUND: Ethanolamine (Etn), a precursor of phosphatidylethanolamine (PE), may alter hepatic lipid homeostasis and gut health; its dietary effects remain undefined. OBJECTIVE: The objective of this study was to determine the effects of dietary Etn on lipid and glucose metabolism and liver/gut health in high-fat diet (HFD)-fed mice, complemented by in vitro hepatocyte assays. METHODS: Ten-wk-old C57BL/6 mice (20 male, 18 female) were fed ad libitum HFD (45% energy from fat) with [Ethanolamine supplementation (ES-group)] or without (CON-group) Etn (8 g/kg diet) for 10 wk. Outcomes included body/liver weight, glucose tolerance test (GTT) results, plasma phosphatidylcholine (PC)/cholesteryl ester (CE)/triacylglycerol (TG) concentrations, hepatic TG/PC/PE concentrations, hepatic endoplasmic reticulum (ER)-stress, and inflammation markers, jejunal morphology/barrier/inflammation genes, and fecal microbiota (α/β diversity). HuH7 cells received 20 μM or 5 mM Etn to assess TG/PC/PE synthesis. STATISTICS: repeated-measures analysis of variance (ANOVA) (GTT), t-test or Wilcoxon (other endpoints), permutational multivariate analysis of variance (PERMANOVA) (β diversity); α=0.05. RESULTS: ES increased hepatic TG in females by 230% compared with CON (P = 0.001), and trended higher in males (P = 0.054); hepatic PC and PE masses were unchanged. In ES males, GTT area under the curve decreased by 22.6% (P = 0.037), and plasma PC, CE, and TG were reduced by: PC -16.6%, CE -24.5%, TG -25.9%, respectively (all P < 0.05). ES males showed higher hepatic Tnf and Cd68 and increased C/EBP homologous protein (CHOP) (all P < 0.05). In vitro, Etn did not alter hepatocellular TG, PC, or PE synthesis (all P > 0.05). Female ES mice exhibited altered fecal β-diversity (PERMANOVA P = 0.006) with early jejunal inflammatory signals (Tnf ↑; P = 0.055). CONCLUSIONS: Dietary Etn modifies hepatic lipid storage and gut microbiota in a sex-dependent manner and improves glucose tolerance in males, whereas in vitro data indicate no direct effect on hepatocyte lipid synthesis.
No takes yet. Share an insight, caveat, or question.
Holdaway et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: